Single-cell Analysis Market worth $5.6 billion by 2025 – Spectrophotometers Play an Integral Role in the Life Sciences Industry

Single-cell Analysis Market

Single-cell Analysis Market

PUNE, India, 2021-Jun-28 — /EPR Network/ — The report “Single-cell Analysis Market by Cell Type (Human, Animal, Microbial), Product (Consumables, Instruments), Technique (Flow Cytometry, NGS, PCR, Mass Spectrometry, Microscopy), Application (Research, Medical Application), End User – Global Forecasts to 2025″, is projected to reach USD 5.6 billion by 2025 from USD 2.1 billion in 2019, at a CAGR of 17.8% during the forecast period.

The growth in Single-cell Analysis Market is driven by technological advancements in single-cell analysis products, increasing government funding for cell-based research, growing biotechnology and biopharmaceutical industries, wide applications of single-cell analysis in cancer research, growing focus on personalized medicine, and the increasing incidence and prevalence of chronic and infectious diseases. However, the high cost of single-cell analysis products is expected to restrain the growth of this market to a certain extent during the forecast period.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=171955254

The flow cytometry segment accounted for the largest single-cell analysis market share.

Based on technique, segmented into flow cytometry, NGS, PCR, microscopy, mass spectrometry, and other techniques. The flow cytometry segment accounted for the largest market share in 2018. The large share of this segment is attributed to the wide usage of flow cytometry in detecting and measuring the physical and chemical characteristics of a population of cells or particles. However, the NGS segment is projected to register the highest growth rate during the forecast period. The high growth of the NGS segment is driven by the increasing application of single-cell analysis products in drug discovery for cancer and other chronic diseases.

NGS is the fastest-growing segment of the single-cell analysis market.

Based on technique, segmented into flow cytometry, NGS, PCR, microscopy, mass spectrometry, and other techniques. The NGS segment is projected to register the highest growth rate of 20.0% during the forecast period. The high growth of the NGS segment is driven by the increasing application of single-cell analysis products in drug discovery for cancer and other chronic diseases.

Download PDF Brochurehttps://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171955254

Asia Pacific market to witness the highest growth during the forecast period;

The global single-cell analysis market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific market is anticipated to witness the highest growth during the forecast period. The presence of a large patient population (especially in China and India), increasing investments in R&D, and growth in the outsourcing of drug discovery services to Asian CROs are some of the major factors driving the demand for single-cell analysis consumables and instruments in this regional market.

Key Market Players;

Prominent players in the single-cell analysis market are Becton, Dickinson and Company (US), Danaher Corporation (US), Merck Millipore (US), QIAGEN (Netherlands), Thermo Fisher Scientific (US), General Electric Company (US), 10x Genomics (US), Promega Corporation (US), Illumina (US), Bio-Rad Laboratories (US), Fluidigm Corporation (US), Agilent Technologies (US), NanoString Technologies (US), Tecan Group (Switzerland), Sartorius AG (Germany), Luminex Corporation (US), Takara Bio (Japan), Fluxion Biosciences (US), Menarini Silicon Biosystems (Italy), and LumaCyte (US).

Matched content

Editor’s pick

Express Press Release Distribution